Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

High unmet medical need for therapies that can reduce the substantial treatment burden affecting millions of patients globallyCombined in-licensing and ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...

When a cold strikes, you want fast, effective relief. And while grabbing the first over-the-counter cold medication seems ...

While wildfires can cause immediate destruction to homes and towns, a few weeks of smoke exposure should not have long-term ...

Dr. Andy Whittamore, a GP and clinical lead at Asthma and Lung UK, shed light on four chronic lung conditions that tend to ...

No link was found between Competitive Bidding Program implementation and changes in supplemental oxygen use or clinical ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges.

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.